Hangwen Li
University of Science and Technology of China(CN)Mirna Therapeutics (United States)(US)Shanghai East Hospital(CN)National Institute for Viral Disease Control and Prevention(CN)
Publications by Year
Research Areas
Cancer Cells and Metastasis, Prostate Cancer Treatment and Research, Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, RNA Interference and Gene Delivery
Most-Cited Works
- → The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44(2011)1,403 cited
- → The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration(2012)319 cited
- → Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer(2013)271 cited
- → PC3 Human Prostate Carcinoma Cell Holoclones Contain Self-renewing Tumor-Initiating Cells(2008)231 cited
- → A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity(2021)126 cited
- → Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients(2021)122 cited